IFL protocol: Clinical Trials

12 trials of IFL protocol, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

12 unknown. 12 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	12	Unknown 12
Phase 3	2	Unknown 2
Phase 1	1	Unknown 1

Follow IFL protocol: new trials by email Literature Review of IFL protocol trials Research Report on IFL protocol

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal Cancer Ametumumab, Anti-PD-1 monoclonal antibody, Cetuximab - Colorectal Cancer	Phase 2	Unknown	Shanghai Celfuture Biotech Co., Ltd.	84	2023-01-01	2023-02-01
The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer Fruquintinib, FOLFIRI, mFOLFOX6 - Metastatic Colorectal Cancer	Phase 2	Unknown	Fudan University	68	2022-12-01	2022-12-02
Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC Cetuximab, mFOLFOX6, FOLFIRI - Colorectal Cancer	Phase 2 / Phase 3	Unknown	Ruijin Hospital	200	2021-11-01	2021-04-30
Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial CAPOX, Capecitabine, FOLFIRI - Colon Cancer	Phase 2	Unknown	IFOM ETS - The AIRC Institute of Molecular Oncology	140	2020-06-16	2023-09-28
Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR Panitumumab - Metastatic Colorectal Cancer	Phase 2	Unknown	King Abdullah Medical City	30	2020-06-10	2022-04-06
A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI FOLFIRI Protocol, SCO-101 - Metastatic Colorectal Cancer	Phase 1 / Phase 2	Unknown	Scandion Oncology A/S	35	2020-05-14	2022-03-02
Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM. oxaliplatin, FOLFIRI Protocol, Bevacizumab - Liver Metastasis Colon Cancer	Phase 2	Unknown	Rabin Medical Center	49	2020-01-01	2020-10-20
Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma Durvalumab, Tremelimumab, FOLFIRI Protocol - Gastric Adenocarcinoma, Gastric Cancer	Phase 2	Unknown	Federation Francophone de Cancerologie Digestive	107	2019-07-17	2024-07-08
Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma FOLFIRI Protocol - Neuroendocrine Carcinoma	Phase 2	Unknown	Peking University	45	2017-05-02	2017-06-01
Cetuximab Monotherapy Maintenance Treatment in mCRC Cetuximab, mFOLFOX6, FOLFIRI - Colorectal Cancer	Phase 2 / Phase 3	Unknown	Ruijin Hospital	500	2016-11-01	2016-11-30
wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients wXELIRI regimen, FOLFIRI regimen - Colorectal Cancer	Phase 2	Unknown	Fudan University	100	2012-05-01	2012-11-29
Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment sorafenib, FOLFIRI - Colorectal Neoplasms	Phase 2	Unknown	Fudan University	43	2008-11-01	2010-09-15

Conditions studied

Sponsors

Countries

Top investigators

Results publications

NIH funding